Lawsuit to be launched over breast cancer gene patent

[News]

BRCA1 and BRCA2 are two genes that have been identified to hold a key to women’s susceptibility to get breast or ovarian cancer. Changes also known as mutations in these genes are significant in women who go on to develop breast or ovarian cancer. Melbourne-based company Genetic Technologies Limited (GTL) has the exclusive license from American biotechnology company Myriad Genetics to carry out testing for the genes in Australia. Myriad holds a patent for these genes.

More... (http://www.news-medical.net/news/20100607/Lawsuit-to-be-launched-over-breast-cancer-gene-patent.aspx)